Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study Assessing Blood Pressure, Cardiovascular, Endothelial and Other Outcomes poSt-surgical and Medical Treatment in Patients With Primary Aldosteronism

NCT03174847 is registered in ClinicalTrials.gov with Changi General Hospital as lead sponsor.

NCT NCT03174847
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03174847 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study Assessing Blood Pressure, Cardiovascular, Endothelial and Other Outcomes poSt-surgical and Medical Treatment in Patients With Primary Aldosteronism
Lead sponsor
Changi General Hospital
Phase
Observational
Overall status
Completed
Start date
February 20, 2017
Completion date
September 20, 2020
Enrollment
57 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary aldosteronism, primary aldosteronism due to adrenal hyperplasia (bilateral), primary aldosteronism due to aldosterone producing adenoma